Short Interest in IMCD (OTCMKTS:IMCDY) Declines By 73.9%

IMCD (OTCMKTS:IMCDYGet Free Report) saw a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 2,912 shares, a decline of 73.9% from the August 15th total of 11,155 shares. Based on an average trading volume of 11,488 shares, the days-to-cover ratio is currently 0.3 days.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. UBS Group raised IMCD to a “buy” rating in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of IMCD in a report on Thursday, July 30th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, IMCD currently has a consensus rating of “Moderate Buy” and an average price target of $72.50.

Get Our Latest Stock Analysis on IMCDY

IMCD Price Performance

Shares of OTCMKTS IMCDY traded down $0.51 during mid-day trading on Monday, reaching $55.80. 1,737 shares of the company traded hands, compared to its average volume of 62,342. IMCD has a fifty-two week low of $39.76 and a fifty-two week high of $61.56. The stock has a fifty day simple moving average of $54.19 and a 200-day simple moving average of $51.64.

IMCD Company Profile

(Get Free Report)

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesives, core materials, filler reinforcements, flame retardants, masterbatch, modifiers, operating materials, pigments, plasticizers, processing aids, PUR raw materials, rubber elastomers, solvents, stabilizers, thermoplastic elastomers, thermoplastics, thermoplastics, and other additives.

Featured Articles

Receive News & Ratings for IMCD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMCD and related companies with MarketBeat.com's FREE daily email newsletter.